Warther Private Wealth’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-464
| Closed | -$294K | – | 67 |
|
2025
Q1 | $294K | Sell |
464
-4,200
| -90% | -$2.66M | 0.1% | 49 |
|
2024
Q4 | $3.32M | Buy |
+4,664
| New | +$3.32M | 1.12% | 21 |
|
2024
Q2 | – | Sell |
-2,398
| Closed | -$2.31M | – | 89 |
|
2024
Q1 | $2.31M | Sell |
2,398
-151
| -6% | -$145K | 1.03% | 28 |
|
2023
Q4 | $2.24M | Sell |
2,549
-837
| -25% | -$735K | 1.25% | 24 |
|
2023
Q3 | $2.79M | Buy |
3,386
+52
| +2% | +$42.8K | 1.85% | 18 |
|
2023
Q2 | $2.4M | Sell |
3,334
-260
| -7% | -$187K | 1.63% | 20 |
|
2023
Q1 | $2.95M | Buy |
3,594
+55
| +2% | +$45.2K | 2.25% | 14 |
|
2022
Q4 | $2.55M | Sell |
3,539
-142
| -4% | -$102K | 1.91% | 18 |
|
2022
Q3 | $2.54M | Buy |
3,681
+1,865
| +103% | +$1.28M | 2.01% | 14 |
|
2022
Q2 | $1.08M | Buy |
1,816
+1,367
| +304% | +$814K | 0.79% | 46 |
|
2022
Q1 | $312K | Buy |
+449
| New | +$312K | 0.2% | 105 |
|